<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The recent availability of two-dimensional echocardiography (2DE) has fostered the expectation that cardiac embolic sources could be identified or excluded with certitude in <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> patients </plain></SENT>
<SENT sid="1" pm="."><plain>As a screening procedure, 2DE has had a low yield </plain></SENT>
<SENT sid="2" pm="."><plain>In selected patients, 2DE holds promise as a useful diagnostic test </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001297'>Stroke</z:hpo> patients who may benefit from 2DE include patients under age 45, patients with suspected left <z:mp ids='MP_0003392'>atrial myxoma</z:mp>, and patients with known infective <z:hpo ids='HP_0100584'>endocarditis</z:hpo>, prosthetic heart valves, or rheumatic <z:hpo ids='HP_0001654'>valvular heart disease</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>In patients with <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e>, the yield of useful information from 2DE will be low but may, on occasion, influence management </plain></SENT>
</text></document>